Every open market buy and sale of Oruka Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $345M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when ORKA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an ORKA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every ORKA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 20, 2026 | Paul T QuinlanGeneral Counsel | Sale plan | 9,000 | $94.89 | $854K | 29,995 | Nov 20Form 4 |
| Nov 16, 2026 | Joana GoncalvesChief Medical Officer | Sale plan | 7,000 | $100.96 | $707K | 31,771 | Nov 16Form 4 |
| Nov 12, 2026 | Kristine M BallDirector | Sale plan | 18,000 | $104.93 | $1.9M | 0 | Nov 13Form 4 |
| Nov 12, 2026 | Arjun AgarwalSenior Vice President, Finance | Sale plan | 10,000 | $104.97 | $1M | 14,219 | Nov 13Form 4 |
| Nov 2, 2026 | Lawrence Otto KleinCEO | Sale plan | 25,000 | $95.61 | $2.4M | 923,128 | Nov 2Form 4 |
| Oct 20, 2026 | Paul T QuinlanGeneral Counsel | Sale plan | 9,000 | $78.53 | $707K | 29,995 | Oct 20Form 4 |
| Oct 15, 2026 | Joana GoncalvesChief Medical Officer | Sale plan | 7,000 | $74.81 | $524K | 31,771 | Oct 15Form 4 |
| Oct 12, 2026 | Arjun AgarwalSenior Vice President, Finance | Sale plan | 9,999 | $80.60 | $806K | 14,219 | Oct 13Form 4 |
| Oct 1, 2026 | Lawrence Otto KleinCEO | Sale plan | 25,000 | $83.62 | $2.1M | 923,128 | Oct 2Form 4 |
| Sep 21, 2026 | Paul T QuinlanGeneral Counsel | Sale plan | 10,000 | $93.64 | $936K | 29,995 | Sep 21Form 4 |
| Sep 21, 2026 | Arjun AgarwalSenior Vice President, Finance | Sale plan | 533 | $95.75 | $51K | 14,219 | Sep 21Form 4 |
| Sep 15, 2026 | Laura Lee SandlerCOO | Sale | 906 | $95.71 | $87K | 235,478 | Sep 15Form 4 |
| Sep 15, 2026 | Paul T QuinlanGeneral Counsel | Sale | 1,039 | $95.71 | $99K | 29,995 | Sep 15Form 4 |
| Sep 15, 2026 | Lawrence Otto KleinCEO | Sale | 2,452 | $95.71 | $235K | 923,128 | Sep 15Form 4 |
| Sep 15, 2026 | Arjun AgarwalSenior Vice President, Finance | Sale plan | 10,019 | $92.43 | $926K | 14,752 | Sep 15Form 4 |
ORKA insider trading FAQ
Are ORKA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of ORKA on the open market in 0 trades, and 8 sold $345M in 47 trades, 13% of that under pre-arranged trading plans.
When did an ORKA insider last buy shares?
VHCP Management III, LLC (10% owner) bought 122,882 shares for $1.4M on Feb 14, 2025, reported on Feb 27, 2025.
When did an ORKA insider last sell shares?
Paul T Quinlan (General Counsel) sold 9,000 shares for $854K on Nov 20, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
